Outlook Therapeutics, Inc. (OTLK): SC 13G/A filed Nov 7, 2024

Form type

SC 13G/A

Filing date

Nov 7, 2024

Accession number

0000921895-24-002509

Filer

Outlook Therapeutics, Inc. (CIK 1649989)